drugset
drugset / Trial / NCT03443453

A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers

NCT03443453 ↗

Phase 1 Completed 18 enrolled Medivir
RandomizedCrossoverOpen-labelOther

Summary

This is a single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics following Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers

Timeline

Start
2018-01-19
Primary completion
2018-02-17
Completion
2018-02-17

Drugs

EvaluationDrugModalityDoseRoute
Subject MIV-711 Unknown — —

Indications

No indication recorded.